Belite Bio, Inc focuses on developing treatments for age-related macular degeneration and related diseases. They are currently in the final phase of clinical trials for their lead product, LBS-008, which helps reduce Vitamin A accumulation in ocular tissue. The company is also developing LBS-009, a treatment for liver disease that is in the preclinical development phase.